A Randomized, Placebo-Controlled, Phase II Study of Tetomilast in Active Ulcerative Colitis

Stefan Schreiber*, Ali Keshavarzian, Kim L. Isaacs, John Schollenberger, Juan P. Guzman, Cesare Orlandi, Stephen B. Hanauer

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'A Randomized, Placebo-Controlled, Phase II Study of Tetomilast in Active Ulcerative Colitis'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science